Table 1.

Cohort demographics. *p < 0.05 (Pearson chi-square test)

	Controls (N = 15)	PD (N = 15)	DLB (N = 15)	p value
Age of death (years ± SD)	77 ± 6	77 ± 5	77 ± 5	0.67
Sex (M/F)	4/11	11/4	10/5	0.02*
Postmortem delay (hours ± SD)	6.3 ± 1.7	6.0 ± 1.8	5.2 ± 1.2	0.47
Braak Lewy Body Score	0–1 (14/1)	4–6 (3/5/7)	4–6 (3/3/9)	< 0.01*
Braak score for Neurofibrillary Tangles	0–2 (2/6/7)	0–3 (2/9/2/2)	0–3 (1/8/5/1)	0.46
CERAD Amyloid Plaque Score	0-B (4/7/4)	O-C (7/5/2/1)	O-C (3/3/8/1)	0.21
Disease duration (years ± SD)	–	15 ± 7	6 ± 3	< 0.01*
No. of donors with GBA risk factors	2	3	4	–
No. of donors with pathogenic GBA variants	0	3	0	–